13.4.2026

Taaleri Acquisition of a majority stake in Nordic Science Investments

Related services

We are acting as legal adviser to Taaleri Plc on its acquisition of a 51 per cent ownership stake in Nordic Science Investments Oy (NSI), marking Taaleri’s expansion into deeptech-driven venture capital. Through the transaction, Taaleri broadens its private equity offering into early-stage venture capital funds as well as the commercialisation and scaling of research-driven innovations.

NSI is a Finnish venture capital fund manager operating across the Nordic and Baltic regions, focusing on early-stage investments in research- and science-based technologies. Its portfolio companies develop, among other things, health technologies, life sciences, advanced materials and AI-driven solutions. In addition to providing growth capital, NSI supports spin-out companies with strategic guidance, access to networks and assistance in building teams during the early phases of business development. NSI’s first fund, the EUR 45 million NSI Nordic Science I Ky, was established in 2024 and has to date invested in 22 early-stage companies in Finland, Sweden and the Baltic countries.

Taaleri is a specialist in investments, private asset management and non-life insurance, with a strong position in renewable energy, bioindustry and housing investments as well as credit risk insurance. Taaleri has EUR 2.7 billion of assets under management in its private equity funds, co-investments and single-asset vehicles, employs approximately 130 people and is listed on Nasdaq Helsinki.

The founders of NSI will continue in their operational roles following the transaction. The completion of the transaction is subject to approval by the FIN-FSA.

Our team

Latest references

Aurevia and Labquality – Strategic reorganisation

We advised Aurevia Oy, a portfolio company of French private equity sponsor Mérieux Equity Partners, in a strategic reorganisation that involved splitting Aurevia and its parent companies into two independent groups of companies and reorganisation of its existing debt-financing arrangements. Following the reorganisation, the newly formed Aurevia continues as a leading provider of Contract Research Organization (CRO) and Quality Assurance and Regulatory Affairs (QARA) services, while the newly formed Labquality focuses on delivering External Quality Assessment (EQA) services. Aurevia serves operators in the medical devices, in vitro diagnostics and pharmaceutical sectors. Labquality’s customers include clinical laboratories and social and healthcare organisations. The reorganisation positions Aurevia and Labquality to allocate investments more effectively, accelerate growth within their respective customer segments, and respond to evolving market and client needs. The transaction was implemented through multiple parallel demergers and required comprehensive legal and tax structuring across several jurisdictions. Our team supported Aurevia throughout the planning and implementation phases, covering corporate, tax, employment law, and regulatory matters, as well as the optimisation of each group’s financing structure.

CapMan Growth – Investment in Kuntokeskus Liikku

We are assisting CapMan Growth in its significant investment in Kuntokeskus Liikku, a Finnish gym chain known for its high-quality self-service facilities and excellent value for money. The investment will further strengthen Liikku’s position as a market leader and support the continued execution of its growth strategy. Liikku is one of Finland’s leading fitness chains, with more than 70 locations across the country serving nearly 90,000 members. The company’s concept is to offer high-quality self-service gyms at an exceptionally competitive price point which, combined with strong operational efficiency, provides a solid foundation for profitable growth. The company’s main shareholder is COR Group, a long-time partner of CapMan Growth, and a Finnish health and wellness conglomerate known for active ownership and long-term value creation. CapMan Growth is a leading Finnish growth investor that makes significant investments in entrepreneur-led growth companies with a turnover of €10–200 million. CapMan Growth is part of CapMan, which is a leading Nordic private equity investor engaged in active value creation work. CapMan has been listed on the Helsinki Stock Exchange since 2001.

GEA – Cornerstone investment in Solar Foods’ share issue

We acted as legal adviser to GEA Group AG in a directed share issue carried out by Solar Foods Oyj, in which GEA Finland Oy, a wholly owned subsidiary of GEA Group AG, acted as a cornerstone investor with an equity investment of EUR 8 million. Solar Foods raised a total of approximately EUR 25 million in gross proceeds from the share issue to accelerate the implementation of its new production facility Factory 02. In connection with the share issue, GEA Liquid Technologies GmbH and Solar Foods signed an exclusivity agreement under which Solar Foods appoints GEA Liquid Technologies as its exclusive process equipment vendor for the supply, design, construction and delivery of the process equipment for the Factory 02. Additionally, the parties have undertaken to negotiate terms and conditions of a long-term strategic partnership in the area of gas fermentation and related technologies. GEA is one of the world’s largest systems suppliers for the food, beverage and pharmaceutical sectors. GEA’s portfolio includes machinery and plants as well as advanced process technology, components and comprehensive services. GEA is listed in the DAX and the STOXX® Europe 600 Index and is also among the companies comprising the DAX 50 ESG and MSCI Global Sustainability Indices. Solar Foods produces Solein®, a protein created using carbon dioxide and electricity. This innovative production method is independent of weather and climate conditions, eliminating the need for traditional agriculture. Founded in Finland in 2017, Solar Foods is listed on the Nasdaq First North Growth Market Finland.

Puhdistamo – PK Consumer Health invests in Puhdistamo

We advised the shareholders in Puhdistamo – Real Foods Oy in the sale of all shares in Puhdistamo to PK Consumer Health. Puhdistamo is a leading Nordic wellbeing company, best known for its high-quality supplements, sports nutrition products and, functional beverages. Puhdistamo employs 120 employees in Finland and Sweden. PK Consumer Health is owned by Avista Healthcare Partners and Damier Group. The sellers will make a reinvestment into PK Consumer Health as part of the transaction. Completion is subject to customary closing conditions.

Search from the site.